Elyxium Wealth’s Sabra Healthcare REIT SBRA Stock Holding History

Elyxium Wealth’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-326	Closed	-$6.17K	–	1057
2025 Q4	$6.17K	Buy	+326	New	+$6.04K	﹤0.01%	884

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Elyxium Wealth's SBRA Position: Q1 2026 in Review

Elyxium Wealth sold out of Sabra Healthcare REIT (SBRA) in Q1 2026, closing a stake of 326 shares — an estimated $6.17K sold.

Elyxium Wealth first reported a position in SBRA in Q4 2025 and held it in 1 quarter. The position peaked at $6.17K in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

Elyxium Wealth reported no remaining Sabra Healthcare REIT position as of Q1 2026 after selling out during the quarter.
Elyxium Wealth sold 326 Sabra Healthcare REIT shares in Q1 2026, an estimated $6.17K.
Elyxium Wealth first reported a position in Sabra Healthcare REIT in Q4 2025 and held it in 1 quarter.
Elyxium Wealth's Sabra Healthcare REIT position peaked at $6.17K in Q4 2025.
463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.